2CL

63.44000 EUR
0.86
1.37%
Last update Dec 15, 8:01 AM CET
Market closed
Day range
63.44000
63.44000
Previous close
62.58000
Open
63.44000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
63.44
0.86
1.37%

Statistics

Valuation metrics
Market cap
0
Enterprise value
893.91M
Trailing P/E (ttm)
-22.03
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
4.73
Enterprise Value/EBITDA
-1.81
Overview
Shares outstanding
192.63M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
5
Average volume (90 days)
2
Price summary
52-Week low
24.71
52-Week high
63.98
52-Week change
58.84 238.1%
Beta
50-Day moving average
54.48
200-Day moving average
40.62
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
98.25%
Operating margin
-199.59%
Operational effectiveness
Return on assets
-58.28%
Return on equity
36.76%
Income statement
Revenue (ttm)
189.01M
Revenue per share (ttm)
1.19
Quarterly revenue growth (yoy)
9.17%
Gross profit (ttm)
185.70M
EBITDA
0
Net income to common (ttm)
-456.34M
Diluted EPS (ttm)
-2.88
Quarterly earnings growth (yoy)
4,252.90%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
1.58B
Total Debt/Equity (mrq)
-0.97
Current ratio (mrq)
387.53%
Book value per share (mrq)
Cash flow
Cash flow statement
-347.77M
Levered free cash flow (LFCF)
-456.34M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 7 hours 26 minutes

00:33
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).